US Stock MarketDetailed Quotes

OCUL Ocular Therapeutix

Watchlist
  • 5.490
  • -0.010-0.18%
Close Jun 18 16:00 ET
  • 5.720
  • +0.230+4.19%
Post 17:53 ET
850.34MMarket Cap-4901P/E (TTM)

About Ocular Therapeutix Company

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Company Profile

SymbolOCUL
Company NameOcular Therapeutix
Listing DateJul 25, 2014
Issue Price13.00
Founded2006
CEODr. Pravin U. Dugel, M.D.
MarketNASDAQ
Employees267
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address15 Crosby Drive
CityBedford
ProvinceMassachusetts
CountryUnited States of America
Zip Code01730
Phone1-781-357-4000
Websitehttp://www.ocutx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Pravin U. Dugel, M.D.
  • Chairman of the Board, President and Chief Executive Officer
  • --
  • Dr. Jeffrey S. Heier, M.D.
  • Chief Scientific Officer
  • 329.90K
  • Dr. Sanjay Nayak, M.B.B.S.,PhD
  • Chief Strategy Officer
  • --
  • Dr. Nadia Waheed, M.D.
  • Chief Medical Officer
  • --
  • Donald Notman
  • Chief Financial Officer and Principal Accounting Officer
  • 1.34M
  • Peter Kaiser, M.D.
  • Director, Medical
  • --
  • Leslie J. Williams
  • Independent Director
  • 261.11K
  • Dr. Seung Suh Hong, PhD
  • Independent Director
  • 248.61K
  • Merilee Raines
  • Independent Director
  • 263.61K
  • Dr. Richard L. Lindstrom,M.D.
  • Independent Director
  • 261.11K
  • Dr. Adrienne L. Graves,PhD
  • Independent Director
  • 397.89K
  • Charles Warden
  • Lead Independent Director
  • 303.61K
  • Philip C. Strassburger
  • General Counsel
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg